Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemonucleolysis vs laminectomy

E J Dabezies, M Brunet

    Orthopedics
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Chemonucleolysis with chymopapain offers a safe and effective treatment for herniated nucleus pulposus syndrome. This minimally invasive procedure demonstrated superior long-term outcomes compared to surgery, with faster recovery and less patient stress.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial.

    ESMO open·2026
    Same author

    Extreme plate boundary localization promotes shallow earthquake slip at the Japan Trench.

    Science (New York, N.Y.)·2025
    Same author

    Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.

    British journal of cancer·2024
    Same author

    Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM).

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Properties of ^{187}Ta Revealed through Isomeric Decay.

    Physical review letters·2020
    Same journal

    Preoperative Copper-to-Zinc Ratio and Postoperative Delirium After Hip Fracture Surgery: A Propensity Score-matched Cohort Study.

    Orthopedics·2026
    Same journal

    Supracondylar Distal Femur Fracture Fixation: Early Experiences Comparing the Retrograde Nail With Locking Attachment Washer (LAW) Plate to Traditional Fixation Techniques.

    Orthopedics·2026
    Same journal

    Intra-Articular Vancomycin Powder in Primary Total Knee Arthroplasty: A Retrospective Observational Study.

    Orthopedics·2026
    Same journal

    Limb Salvage Versus Amputation for the Management of Primary Bone Tumors of the Upper Extremity: A Systematic Review.

    Orthopedics·2026
    Same journal

    A Modified Keshishyan Index Demonstrates Three-dimensional Assessment of Asymmetry in Pediatric Pelvic Fractures.

    Orthopedics·2026
    Same journal

    Planned Versus Intraoperative Vascular Surgery Consultations in Orthopedic Oncology.

    Orthopedics·2026
    See all related articles

    Area of Science:

    • Neurosurgery
    • Minimally Invasive Procedures
    • Biologics

    Background:

    • Herniated nucleus pulposus syndrome is a common cause of low back pain.
    • Traditional surgical interventions carry risks and prolonged recovery times.
    • Chemonucleolysis offers a less invasive alternative for treating disc herniation.

    Purpose of the Study:

    • To evaluate the safety and efficacy of chemonucleolysis using chymopapain.
    • To compare the outcomes of chemonucleolysis with traditional surgical treatment.
    • To assess the long-term results and patient-reported outcomes of chemonucleolysis.

    Main Methods:

    • A cohort of 100 patients with herniated nucleus pulposus syndrome underwent chemonucleolysis with chymopapain.
    • Patients were followed up for two years post-treatment.

    Related Experiment Videos

  • Outcomes were compared to a control group of 100 patients who underwent surgery.

    • Main Results:

    • Chemonucleolysis showed no significant allergic reactions, deaths, spinal cord injury, or paralysis.
    • 71% of chemonucleolysis patients achieved good to excellent results, compared to 63% in the surgical group.
    • Treatment led to faster achievement of results and reduced physiologic stress.

    Conclusions:

    • Chemonucleolysis with chymopapain is a safe and effective treatment for herniated nucleus pulposus syndrome.
    • The procedure yields superior long-term results compared to surgery.
    • Chemonucleolysis offers a faster, less stressful, and high-quality outcome for patients.